{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T22:06:31Z","timestamp":1784844391797,"version":"3.55.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":20,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-34518-x","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T07:23:56Z","timestamp":1768289036000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Hypertension and other comorbidities associated with increased mortality in hospitalized adult patients with COVID-19 in spain: a descriptive, retrospective, nationwide study"],"prefix":"10.1038","volume":"16","author":[{"given":"Ruth","family":"Gil-Prieto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valent\u00edn","family":"Hernandez-Barrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Mar\u00edn-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba","family":"Gonz\u00e1lez-Escalada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngel","family":"Gil-de-Miguel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,13]]},"reference":[{"issue":"4","key":"34518_CR1","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/s41564-020-0695-z","volume":"5","author":"Coronaviridae Study Group of the International Committee on Taxonomy of Viruses","year":"2020","unstructured":"Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat. Microbiol. 5 (4), 536\u2013544 (2020). 2.","journal-title":"Nat. Microbiol."},{"issue":"9","key":"34518_CR2","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1177\/0145561320920762","volume":"99","author":"A Lovato","year":"2020","unstructured":"Lovato, A. & de Filippis, C. Clinical presentation of COVID-19: a systematic review focusing on upper airway symptoms. Ear Nose Throat J. 99 (9), 569\u2013576 (2020).","journal-title":"Ear Nose Throat J."},{"key":"34518_CR3","unstructured":"World Health Organization. WHO Director-General\u2019s opening remarks at the media briefing on COVID-19\u201311 March 2020 [Internet]. Available from: https:\/\/www.who.int\/director-general\/speeches\/detail\/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020"},{"key":"34518_CR4","first-page":"371m4509","volume":"27","author":"R Pastor-Barriuso","year":"2020","unstructured":"Pastor-Barriuso, R. et al. Infection fatality risk for SARS-CoV-2 in community dwelling population of spain: nationwide seroepidemiological study. BMJ 27, 371m4509 (2020).","journal-title":"BMJ"},{"issue":"1","key":"34518_CR5","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.eimc.2024.08.012","volume":"43","author":"P Arrazola","year":"2025","unstructured":"Arrazola, P. et al. New COVID-19 vaccination recommendations in spain: optimizing for next seasons. Enferm Infecc Microbiol. Clin. 43 (1), 36\u201346 (2025). PMID: 39845334; PMCID: PMC11752446.","journal-title":"Enferm Infecc Microbiol. Clin."},{"key":"34518_CR6","unstructured":"Underlying Conditions and the Higher. Risk for Severe COVID-19 | COVID-19 | CDC https:\/\/www.cdc.gov\/covid\/hcp\/clinical-care\/underlying-conditions.html"},{"key":"34518_CR7","unstructured":"COVID-19 Provisional Counts - Health Disparities. (cdc.gov) https:\/\/www.cdc.gov\/nchs\/nvss\/vsrr\/covid19\/health_disparities.htm#RaceHispanicOriginAge"},{"issue":"4","key":"34518_CR8","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1093\/cid\/ciab493","volume":"74","author":"Y Zhang","year":"2022","unstructured":"Zhang, Y. et al. Risk factors for death among the first 80 543 coronavirus disease 2019 (COVID-19) cases in china: relationships between Age, underlying disease, case Severity, and region. Clin. Infect. Dis. 74 (4), 630\u2013638. https:\/\/doi.org\/10.1093\/cid\/ciab493 (2022). PMID: 34043784; PMCID: PMC8244662.","journal-title":"Clin. Infect. Dis."},{"key":"34518_CR9","unstructured":"CDC. COVID-19 Monthly Death Rates per 100,000 Population by age group, race and ethnicity, and sex. Available online: https:\/\/covid.cdc.gov\/covid-data-tracker\/#demographicsovertime (accessed on 17 February 2024)."},{"key":"34518_CR10","doi-asserted-by":"publisher","first-page":"1113793","DOI":"10.3389\/fpubh.2023.1113793","volume":"11","author":"K Keller","year":"2023","unstructured":"Keller, K. et al. Predisposing factors for admission to intensive care units of patients with COVID-19 infection\u2014Results of the German nationwide inpatient sample. Front. Public. Health. 11, 1113793. https:\/\/doi.org\/10.3389\/fpubh.2023.1113793 (2023).","journal-title":"Front. Public. Health"},{"key":"34518_CR11","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1161\/HYPERTENSIONAHA.112.193078","volume":"60","author":"JR Banegas","year":"2012","unstructured":"Banegas, J. R. et al. Achievement of cardiometabolic goals in aware hypertensive patients in spain: a nationwide population-based study. Hypertension 60, 898\u2013905. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.112.193078 (2012).","journal-title":"Hypertension"},{"key":"34518_CR12","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.recesp.2015.11.036","volume":"69","author":"E Men\u00e9ndez","year":"2016","unstructured":"Men\u00e9ndez, E. et al. Prevalencia, diagn\u00f3stico, Tratamiento y control de La hipertensi\u00f3n arterial En Espa\u00f1a. Resultados Del estudio Di@bet.es. Rev. Esp. Cardiol. 69, 572\u2013578 (2016).","journal-title":"Rev. Esp. Cardiol."},{"key":"34518_CR13","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1161\/CIRCOUTCOMES.114.001191","volume":"8","author":"JR Banegas","year":"2015","unstructured":"Banegas, J. R. et al. Trends in hypertension control among the older population of Spain from 2000\u20132001 to 2008\u20132010: the role of frequency and intensity of drug treatment. Circ. Cardiovasc. Qual. Outcomes. 8, 67\u201376 (2015).","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"34518_CR14","doi-asserted-by":"publisher","unstructured":"Jos\u00e9, R. et al. Mercedes S\u00e1nchez-Mart\u00ednez, Teresa Gij\u00f3n-Conde, Esther L\u00f3pez-Garc\u00eda, Auxiliadora Graciani, Pilar Guallar-Castill\u00f3n,. Cifras e impacto de la hipertensi\u00f3n arterial en Espa\u00f1a. Rev Esp Cardiol. (2024). https:\/\/doi.org\/10.1016\/j.recesp.2024.03.002","DOI":"10.1016\/j.recesp.2024.03.002"},{"key":"34518_CR15","unstructured":"Ministerio de Sanidad. Registro de Atenci\u00f3n Especializada (RAE-CMBD). Desde 2016 en adelante Consulta Interactiva del SNS (sanidad.gob.es). Jul (2024). https:\/\/pestadistico.inteligenciadegestion.sanidad.gob.es\/publicoSNS\/N\/rae-cmbd\/rae-cmbd. Accessed 3."},{"key":"34518_CR16","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1186\/s12879-023-08454-y","volume":"23","author":"R Garcia-Carretero","year":"2023","unstructured":"Garcia-Carretero, R. et al. Hospitalization burden and epidemiology of the COVID-19 pandemic in Spain (2020\u20132021). BMC Infect. Dis. 23, 476. https:\/\/doi.org\/10.1186\/s12879-023-08454-y (2023).","journal-title":"BMC Infect. Dis."},{"key":"34518_CR17","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1001\/jamainternmed.2020.0994","volume":"180","author":"C Wu","year":"2020","unstructured":"Wu, C. et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern. Med. 180, 934\u2013943 (2020). [CrossRef] [PubMed].","journal-title":"JAMA Intern. Med."},{"key":"34518_CR18","doi-asserted-by":"publisher","first-page":"493","DOI":"10.15585\/mmwr.mm7218a4","volume":"72","author":"FB Ahmad","year":"2023","unstructured":"Ahmad, F. B., Cisewski, J. A., Xu, J. & Anderson, R. N. COVID-19 mortality Update\u2014United States, 2022. MMWR Morb Mortal. Wkly. Rep. 72, 493\u2013496 (2023). [CrossRef] [PubMed].","journal-title":"MMWR Morb Mortal. Wkly. Rep."},{"key":"34518_CR19","doi-asserted-by":"publisher","first-page":"105500","DOI":"10.1016\/j.jcv.2023.105500","volume":"165","author":"EY Klein","year":"2023","unstructured":"Klein, E. Y. et al. Severity outcomes associated with SARS-CoV-2 XBB variants, an observational analysis. J. Clin. Virol. 165, 105500 (2023). [CrossRef] [PubMed].","journal-title":"J. Clin. Virol."},{"key":"34518_CR20","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.15585\/mmwr.mm7240a3","volume":"72","author":"CA Taylor","year":"2023","unstructured":"Taylor, C. A. et al. COVID-19-Associated hospitalizations among U.S. Adults Aged\u2009\u2265\u200965 Years\u2014COVID-NET, 13 States, January\u2013August 2023. MMWR Morb Mortal. Wkly. Rep. 72, 1089\u20131094 (2023). [CrossRef] [PubMed].","journal-title":"MMWR Morb Mortal. Wkly. Rep."},{"key":"34518_CR21","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/irv.12504","volume":"12","author":"BL Coleman","year":"2018","unstructured":"Coleman, B. L., Fadel, S. A., Fitzpatrick, T. & Thomas, S. M. Risk factors for serious outcomes associated with influenza illness in high- versus low- and middle-income countries: systematic literature review and meta-analysis. Influenza Other Respir Viruses. 12, 22\u201329 (2018). [CrossRef] [PubMed].","journal-title":"Influenza Other Respir Viruses"},{"key":"34518_CR22","doi-asserted-by":"publisher","first-page":"ofad599","DOI":"10.1093\/ofid\/ofad599","volume":"10","author":"EA Famati","year":"2023","unstructured":"Famati, E. A. et al. Association of chronic medical conditions with severe outcomes among nonpregnant adults 18\u201349 years old hospitalized with Influenza, FluSurv-NET, 2011\u20132019. Open. Forum Infect. Dis. 10, ofad599 (2023). [CrossRef].","journal-title":"Open. Forum Infect. Dis."},{"key":"34518_CR23","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.15585\/mmwr.mm7137a4","volume":"71","author":"S Adjei","year":"2022","unstructured":"Adjei, S. et al. Mortality risk among patients hospitalized primarily for COVID-19 during the Omicron and delta variant pandemic Periods\u2014United States, April 2020-June 2022. MMWR Morb Mortal. Wkly. Rep. 71, 1182\u20131189 (2022). [CrossRef].","journal-title":"MMWR Morb Mortal. Wkly. Rep."},{"issue":"1","key":"34518_CR24","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/s41467-023-44276-x","volume":"15","author":"IL Ward","year":"2024","unstructured":"Ward, I. L. et al. Risk of COVID-19 death in adults who received booster COVID-19 vaccinations in England. Nat. Commun. 15 (1), 398. https:\/\/doi.org\/10.1038\/s41467-023-44276-x (2024). PMID: 38228613; PMCID: PMC10791661.","journal-title":"Nat. Commun."},{"key":"34518_CR25","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S1473-3099(09)70175-6","volume":"9","author":"KM Kunisaki","year":"2009","unstructured":"Kunisaki, K. M. & Janoff, E. N. Influenza in immunosuppressed populations: A review of infection frequency, morbidity, mortality, and vaccine responses. Lancet Infect. Dis. 9, 493\u2013504 (2009). [CrossRef] [PubMed].","journal-title":"Lancet Infect. Dis."},{"key":"34518_CR26","doi-asserted-by":"crossref","unstructured":"Fung, M. & Babik, J. M. COVID-19 in immunocompromised hosts: what we know so Far. Clin. Infect. Dis. 72, 340\u2013350 (2021).\u00a0","DOI":"10.1093\/cid\/ciaa863"},{"key":"34518_CR27","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1097\/QAD.0000000000003597","volume":"37","author":"F Wit","year":"2023","unstructured":"Wit, F. et al. Valk, M. COVID-19 in people with HIV in the Netherlands. AIDS 37, 1671\u20131681 (2023). [CrossRef] [PubMed].","journal-title":"AIDS"},{"key":"34518_CR28","doi-asserted-by":"crossref","unstructured":"Ulrichs, T. et al. Changing epidemiology of COVID-19: potential future impact on vaccines and vaccination strategies. Expert Rev. Vaccines. 23 (1), 510\u2013522 (2024).\u00a0","DOI":"10.1080\/14760584.2024.2346589"},{"issue":"5","key":"34518_CR29","doi-asserted-by":"publisher","first-page":"514","DOI":"10.3390\/vaccines12050514","volume":"12","author":"E Nham","year":"2024","unstructured":"Nham, E. et al. COVID-19 vaccination strategies in the endemic period: lessons from influenza. Vaccines (Basel). 12 (5), 514. https:\/\/doi.org\/10.3390\/vaccines12050514 (2024). PMID: 38793765; PMCID: PMC11125835.).","journal-title":"Vaccines (Basel)"},{"issue":"7","key":"34518_CR30","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/S1473-3099(23)00058-0","volume":"23","author":"H Chemaitelly","year":"2023","unstructured":"Chemaitelly, H. et al. Long-term COVID-19 booster effectiveness by infection history and clinical vulnerability and immune imprinting: a retrospective population-based cohort study. Lancet Infect. Dis. 23 (7), 816\u2013827. https:\/\/doi.org\/10.1016\/S1473-3099(23)00058-0 (2023). Epub 2023 Mar 10. PMID: 36913963; PMCID: PMC10079373.","journal-title":"Lancet Infect. Dis."},{"key":"34518_CR31","doi-asserted-by":"publisher","first-page":"1272961","DOI":"10.3389\/fpubh.2023.1272961","volume":"11","author":"P Singh","year":"2024","unstructured":"Singh, P. et al. Impact of COVID-19 vaccination: a global perspective. Front. Public. Health. 11, 1272961. https:\/\/doi.org\/10.3389\/fpubh.2023.1272961 (2024). PMID: 38274537; PMCID: PMC10808156.","journal-title":"Front. Public. Health"},{"key":"34518_CR32","doi-asserted-by":"publisher","unstructured":"Melnikow, J. et al. Patient concerns and physician strategies for addressing COVID-19 vaccine hesitancy. Vaccine. 42\u00a0(14):3300\u20133306. (2024). https:\/\/doi.org\/10.1016\/j.vaccine.2024.04.025. PMID: 38627148.","DOI":"10.1016\/j.vaccine.2024.04.025"},{"key":"34518_CR33","unstructured":"Casos humanos de infecci\u00f3n por nuevo virus de la gripe AH1N1 en Espa\u00f1a. (sanidad.gob.es) https:\/\/www.sanidad.gob.es\/areas\/promocionPrevencion\/vacunaciones\/programasDeVacunacion\/gripe\/docs\/Recomendaciones_vacunacion_gripe2019_2020.pdf Recomendaciones de vacunaci\u00f3n Frente a La gripe temporada 2019\u20132020 consejo interterritorial."},{"key":"34518_CR34","unstructured":"Casos humanos de infecci\u00f3n por nuevo virus de la gripe AH1N1 en Espa\u00f1a. (sanidad.gob.es) https:\/\/www.sanidad.gob.es\/areas\/promocionPrevencion\/vacunaciones\/programasDeVacunacion\/gripe\/docs\/Recomendaciones_vacunacion_gripe2020_2021.pdf recomendaciones de vacunaci\u00f3n frente a la gripe temporada 2020\u20132021"},{"key":"34518_CR35","doi-asserted-by":"crossref","unstructured":"Kontis, V. et al. Magnitude, demographics and dynamics of the effect of the first wave of the COVID-19 pandemic on all-cause mortality in 21 industrialized countries. Nat Med. 26, 1919\u20131928. (2020).","DOI":"10.1038\/s41591-020-1112-0"},{"key":"34518_CR36","doi-asserted-by":"crossref","unstructured":"Wright, A. et al. The invisible epidemic: neglected chronic disease management during COVID-19. J. Gen. Intern. Med. 35, 2816\u2013 2817. (2020).","DOI":"10.1007\/s11606-020-06025-4"},{"key":"34518_CR37","doi-asserted-by":"publisher","first-page":"651","DOI":"10.33588\/rn.2907.99330","volume":"29","author":"S Peir\u00f3","year":"1999","unstructured":"Peir\u00f3, S. & Librero, J. Evaluaci\u00f3n de Calidad a partir Del Conjunto m\u00ednimo de Datos b\u00e1sicos al Alta hospitalaria. Revisi\u00f3n Neurol. 29, 651\u2013661. https:\/\/doi.org\/10.33588\/rn.2907.99330 (1999).","journal-title":"Revisi\u00f3n Neurol."},{"key":"34518_CR38","doi-asserted-by":"publisher","first-page":"77","DOI":"10.54886\/scire.v24i1.4506","volume":"24","author":"GM Cuenca","year":"2018","unstructured":"Cuenca, G. M. & Salvador Oliv\u00e1n, J. A. From MBDS to big data: A hospital information system for the 21st century. Scire 24, 77\u201389 (2018).","journal-title":"Scire"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34518-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34518-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34518-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T10:05:13Z","timestamp":1770026713000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34518-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,13]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["34518"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-34518-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,13]]},"assertion":[{"value":"29 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"RGP and AGM have received travel and research grants and have participated in advisory boards from Sanofi, Merck, Pfizer, Seqirus and Moderna. VHB, PMG and AGE have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This retrospective study was approved by the Research and Ethics Committee of Rey Juan Carlos University, which ruled that no formal ethics approval was required. The personal information of each subject was delivered to the researchers anonymously and was and deidentifed before the analysis, in strict compliance with the current Spanish and European legislation. All procedures involving human participants were conducted in accordance with the ethical standards of the responsible institutional and\/or National Research Committee and with the tenets of the 1964 Helsinki Declaration and its later amendments and comparable ethical standards. The informed consent was waived by the Research and Ethics Committee of our institution because of the retrospective nature of the study and the analysis used anonymous clinical data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"4439"}}